Klein Matthew B. bought CLPT
May 19, 2026 · Form 4 insider transaction
Klein Matthew B. bought 12,417 shares of ClearPoint Neuro, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
12,417
Price
N/A
Total value
N/A
InsiderKlein Matthew B.
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 19, 2026
Filing dateMay 21, 2026
Shares owned after62,935
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. On May 22, 2025, the reporting person was granted 12,417 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.